These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8385835)

  • 21. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
    Elmore LW; Sirica AE
    Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
    Sirica AE; Radaeva S; Caran N
    Am J Pathol; 1997 Dec; 151(6):1685-94. PubMed ID: 9403719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian disruption accelerates liver carcinogenesis in mice.
    Filipski E; Subramanian P; Carrière J; Guettier C; Barbason H; Lévi F
    Mutat Res; 2009; 680(1-2):95-105. PubMed ID: 19833225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary tumors of the liver.
    Colombari R; Tsui WM
    Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
    [No Abstract]   [Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histologic diagnosis of hepatic tumors.
    Goodman ZD
    Ann Clin Lab Sci; 1984; 14(3):169-78. PubMed ID: 6329068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early changes in cholestatic livers as a consequence of hepatic duct carcinoma: a histological and histochemical exploration.
    James J; Frederiks WM; Van Noorden CJ
    Semin Liver Dis; 1990 May; 10(2):91-101. PubMed ID: 2162570
    [No Abstract]   [Full Text] [Related]  

  • 31. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
    Ohshima M; Ward JM; Brennan LM; Creasia DA
    J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T; Kanematsu T; Sonoda T; Sugimachi K
    Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic hepatocarcinogenesis in the rat.
    Hully JR; Su Y; Lohse JK; Griep AE; Sattler CA; Haas MJ; Dragan Y; Peterson J; Neveu M; Pitot HC
    Am J Pathol; 1994 Aug; 145(2):384-97. PubMed ID: 8053496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver.
    Rouquet N; Allemand I; Molina T; Bennoun M; Briand P; Joulin V
    Oncogene; 1995 Sep; 11(6):1061-7. PubMed ID: 7566965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal xenobiotic resistance during pollution-induced toxic injury and hepatocellular carcinogenesis in liver of female flounder (Platichthys flesus (L.)).
    Koehler A; Alpermann T; Lauritzen B; Van Noorden CJ
    Acta Histochem; 2004; 106(2):155-70. PubMed ID: 15147637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus-like particles observed in transplantable intrahepatic bile duct carcinomas and hepatoma of Syrian golden hamsters.
    Mori H; Hayashi K; Kato T; Hirono I
    Gan; 1973 Feb; 64(1):79-81. PubMed ID: 4352327
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatocellular carcinomas of the albumin SV40 T-antigen transgenic rat display fetal-like re-expression of lgf2 and deregulation of H19.
    Czarny MJ; Babcock K; Baus RM; Manoharan H; Pitot HC
    Mol Carcinog; 2007 Sep; 46(9):747-57. PubMed ID: 17393425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of liver tumors in transforming growth factor alpha transgenic mice.
    Lee GH; Merlino G; Fausto N
    Cancer Res; 1992 Oct; 52(19):5162-70. PubMed ID: 1327502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.